-
Specialties
Board Certification
American Board of Internal MedicineAmerican Board of Internal Medicine (Sub: Rheumatology)Patient Rating
5.0 /5( out of 110 reviews )The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety.
Patients are de-identified for confidentiality and patient privacy.October 29, 2024SUGAR HOUSE HEALTH CENTERSeeing Tawnie is always a great experience. Her warmth, patience, and understanding are over the top. She exceeds my expectations with every visit. Her personality is unmatched.
October 14, 2024SUGAR HOUSE HEALTH CENTERListens when you talk, helps you understand what is happening.
October 08, 2024UH HOSPITALS AND CLINICSDr Braaten us thoughtful, caring and gives you her full attention.
October 06, 2024UH HOSPITALS AND CLINICSCompassionate, knowledgeable, the best physician I have ever
September 30, 2024SUGAR HOUSE HEALTH CENTERCan't say enough about Dr Braaten - she has compassionately cared for me for a number of years - always open to discussion about my concerns and wanting to help me.
September 25, 2024UH HOSPITALS AND CLINICSThe above ratings would not allow me to mark them, so recognize that Doctor Braaten was very effective and through in her examination and questions.
September 08, 2024UH HOSPITALS AND CLINICSI absolutely love Dr. Braaten she only has my best interest in her mind. I have been very sick since Dec. 27,2023¿. being sick that long and having one thing after another stop my recovery. She has gotten me into to the office more often. She is doing a lot of research on my issues. I KNOW that she cares about me. She is a gift.
June 08, 2024SUGAR HOUSE HEALTH CENTERThe best doctor you will ever have! She is a caring, wonderful person!
June 07, 2024UH HOSPITALS AND CLINICSDr.Braaten was very thorough in reviewing my history, and in examining me. She checked every single joints carefully. She is very kind, engaging, and caring. She is a superb physician who is competent and compassionate. I already gave her name to my church member. I had to wait for the first appointment for a long time, but it was worth it.
-
Board Certification and Academic Information
Academic Departments Internal Medicine -Primary Academic Divisions Rheumatology
Board Certification American Board of Internal MedicineAmerican Board of Internal Medicine (Sub: Rheumatology)Education history
Postdoctoral Fellowship Rheumatology - Johns Hopkins University Postdoctoral Fellow Rheumatology - University of Utah School of Medicine Fellow Residency Internal Medicine - University of Utah School of Medicine Resident Medicine - University of Washington School of Medicine M.D. Undergraduate Chemistry - Concordia College B.A. Selected Publications
Journal Article
- Braaten TJ, Brahmer JR, Forde PM, Le D, Lipson EJ, Naidoo J, Schollenberger M, Zheng L, Bingham CO, Shah AA, Cappelli LC (2019). Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation. Ann Rheum Dis, 79(3), 332-338. (Read full article)
- Braaten TJ, Zhang, C, Presson, AP, Breviu, B, Clegg, D, Walsh, JA (2019). Gender Differences in Psoriatic Arthritis With Fatigue, Pain, Function, and Work Disability. J Psoriasis Psoriatic Arthritis, 4(4), 192-197.
- Saxena R, Georgopoulos NA, Braaten TJ, Bjonnes AC, Koika V, Panidis D, Welt CK (2015). Han Chinese polycystic ovary syndrome risk variants in women of European ancestry: relationship to FSH levels and glucose tolerance. Hum Reprod, 30(6), 1454-9. (Read full article)
Case Report
- Calabrese C, Cappelli LC, Kostine M, Kirchner E, Braaten T, Calabrese L (2019). Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature. RMD Open, 5(1), e000906. (Read full article)
Letter
- Cappelli LC, Bingham CO, Braaten T, Shah AA (2020). Response to: Correspondence on "Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation" by Braaten et al. [Letter to the editor]. Ann Rheum Dis, 81(1), e14. (Read full article)